G

Genex Pharmaceutical Inc
OTC:GENX

Watchlist Manager
Genex Pharmaceutical Inc
OTC:GENX
Watchlist
Price: 0.0001 USD
Market Cap: 110.6k USD

Intrinsic Value

GENX latest financial reports are more than 15 years old.
GENX doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of GENX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GENX Intrinsic Value
Not Available
G
Base Case Scenario
Compare GENX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GENX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Genex Pharmaceutical Inc

Current Assets 2.1m
Cash & Short-Term Investments 430k
Receivables 1.2m
Other Current Assets 485k
Non-Current Assets 6.5m
PP&E 196k
Other Non-Current Assets 6.3m
Current Liabilities 3.5m
Accounts Payable 779k
Accrued Liabilities 889.6k
Other Current Liabilities 1.8m
Non-Current Liabilities 431k
Other Non-Current Liabilities 431k
Efficiency

Free Cash Flow Analysis
Genex Pharmaceutical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Genex Pharmaceutical Inc

Revenue
3.2m USD
Cost of Revenue
-362.8k USD
Gross Profit
2.9m USD
Operating Expenses
-2.4m USD
Operating Income
466.1k USD
Other Expenses
-123.5k USD
Net Income
342.6k USD
Fundamental Scores

GENX Profitability Score
Profitability Due Diligence

Genex Pharmaceutical Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Positive 3Y Average ROE
Strong 3Y Average Operating Margin
56/100
Profitability
Score

Genex Pharmaceutical Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

GENX Solvency Score
Solvency Due Diligence

Genex Pharmaceutical Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
50/100
Solvency
Score

Genex Pharmaceutical Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GENX Price Targets Summary
Genex Pharmaceutical Inc

There are no price targets for GENX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Genex Pharmaceutical Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for GENX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y